Hopefully this is BP last chance to make a little cash before Leronlimab arrives on the scene. Must be nice for Roche and Sanofi to be able to keep jumping trial to trial waiting for some type of improvement to stick. Then they figure, let's put both of our weak drugs together to see if they can make something happen. VIOLA! They finally showed improvement in deaths, if taken early by men 23-34 with black hair and under 6 ft tall- I embellished a little, but it seems they keep trying til it works on someone. Now they're gonna sell it quick to the UK at bloated prices before the US ask them to do a true trial, under FDA control. As I've heard on the board before, at least the bar is set low for us to skip over and kick Big Pharm in the teeth with a true savior. I just hope the media praises us with the attention we deserve. Go CYDY!